Skip to main navigation
Skip to main content
Denali Therapeutics
  • Home
  • Scientific Approach
    • GENETIC PATHWAY POTENTIAL
    • ENGINEERING BRAIN DELIVERY
    • BIOMARKER-DRIVEN DEVELOPMENT
    • PUBLICATIONS
  • Pipeline
  • Patients
  • Investor & Media Relations
    • Press Releases
    • Events
    • SEC Filings
    • Corporate Governance
    • Analyst Coverage
  • Leadership
  • Partnering
  • Careers
    • Job Openings
    • STEM Outreach Overview
    • Student Internships
    • Postdoc Program
  • Contact

SEC Filings

Sign Up For Updates
Filing date Form Description View
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034764.pdf
0001209191-20-034764.rtf
0001209191-20-034764.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034767.pdf
0001209191-20-034767.rtf
0001209191-20-034767.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034772.pdf
0001209191-20-034772.rtf
0001209191-20-034772.xls
Jun 05, 2020 4 Statement of changes in beneficial ownership of securities View HTML
0001209191-20-034771.pdf
0001209191-20-034771.rtf
0001209191-20-034771.xls
May 07, 2020 8-K Report of unscheduled material events or corporate event View HTML
0001714899-20-000052.pdf
0001714899-20-000052.rtf
0001714899-20-000052.xls
May 07, 2020 10-Q Quarterly report which provides a continuing view of a company's financial position View HTML
0001714899-20-000053.pdf
0001714899-20-000053.rtf
0001714899-20-000053.xls
Apr 22, 2020 DEF 14A Official notification to shareholders of matters to be brought to a vote ("Proxy") View HTML
0001714899-20-000041.pdf
0001714899-20-000041.rtf
0001714899-20-000041.xls
Apr 22, 2020 DEFA14A Additional proxy soliciting materials - definitive View HTML
0001714899-20-000042.pdf
0001714899-20-000042.rtf
0001714899-20-000042.xls
Apr 02, 2020 8-K Report of unscheduled material events or corporate event View HTML
0001714899-20-000034.pdf
0001714899-20-000034.rtf
0001714899-20-000034.xls
Apr 01, 2020 4/A Amendment to a previously filed 4 View HTML
0001209191-20-022234.pdf
0001209191-20-022234.rtf
0001209191-20-022234.xls
Pagination
  • First page «
  • Previous page ‹
  • …
  • Page 46
  • Page 47
  • Current page 48
  • Page 49
  • Page 50
  • …
  • Next page ›
  • Last page »
Displaying 471 - 480 of 696 results

Sign up for email alerts

Stay in the loop with updates on the latest Denali news delivered right to your inbox


  • Investor & Media Relations

CONTACT US

161 Oyster Point Blvd- South San Francisco, CA 94080

© 2025 Denali Therapeutics

  • Privacy Policy
  • Terms of Use

©2025 Denali Therapeutics | 161 Oyster Point Boulevard, South San Francisco, CA 94080

  • Privacy Policy
  • Terms of Use